{"id":"W2117992805","doi":"10.1093/annonc/mdu021","title":"Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer","year":2014,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Astellas Pharma; Eisai; Genentech; AstraZeneca; Les Laboratories Pierre Fabre; Celgene; GlaxoSmithKline; Pfizer","keywords":"Everolimus; Medicine; Breast cancer; Cancer; Internal medicine; Oncology; Adverse effect; Population; Hormonal therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006702709,0.0005618637,0.001377597,0.0008932422,0.0001554756,0.0006828763,0.0006320248,0.0006599366,0.001813145],"category_scores_gemma":[0.001198628,0.0001540022,0.0006901753,0.0008760025,0.0001765176,0.0004810284,0.0003735662,0.001280486,0.0003928701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003768369,"about_ca_system_score_gemma":0.000677996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007204809,"about_ca_topic_score_gemma":0.002349799,"domain_scores_codex":[0.9998036,0.00004060501,0.00003922731,0.00003396512,0.0000643303,0.00001829396],"domain_scores_gemma":[0.9995217,0.0002409703,0.0001135406,0.000006837482,0.00008723737,0.00002968849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001377817,0.00004480772,0.0005838467,0.007872243,0.000182699,0.0001237631,0.00001842841,0.0002609593,0.000480651,0.0005011441,0.01301328,0.9767804],"study_design_scores_gemma":[0.0004512955,0.0009929579,0.01406078,0.01995472,0.002440042,0.005516031,0.0001791922,0.0008679138,0.001237483,0.003159122,0.9510505,0.0000898359],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002400428,0.9989057,0.00009577574,0.0002302454,0.0001118392,0.000002882118,0.00001427222,0.000004879229,0.0003943896],"genre_scores_gemma":[0.002589419,0.9960971,0.0002807383,0.0003526511,0.0003330789,0.000006864448,0.00004230744,0.00000171704,0.0002961019],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001813145,"threshold_uncertainty_score":0.006065547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03595096550956829,"score_gpt":0.3884343527357096,"score_spread":0.3524833872261414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}